Blogs, Rare diseases

Early access programs – benefits, challenges and the Sciensus solution

Thought Leadership, Rare diseases

Strategies for entering the European orphan drugs market 

Patient Stories

Tracey is still ‘baking up a storm’ thanks to medication service

Patient Stories

New drugs helping Deborah to get back to the life she loved

Thought Leadership, Rare diseases

Realise your European orphan drug expansion

Patient Stories

Nursing care praised by Sciensus cancer patient

Patient Stories

Crohn’s disease patient explains how treatment leaves her feeling “absolutely wonderful”

Thought Leadership, Rare diseases

Take the risk out of your orphan drug distribution in Europe

Thought Leadership, Rare diseases

EU orphan drug roll out: navigating regulatory challenges